Important! Johns Hopkins alumni - if you have recently logged into alumni.jhu.edu to access your alumni email account or KnowledgeNET, giving.jhu.edu to make a gift, or events.jhu.edu to register for an event, you will need to reset your password between May 13 – May 28 at 11:59 PM ET to avoid a disruption in accessing your alumni resources. Click here to learn more about our new security changes.

U.S. Healthcare/Pharma Reimbursement Market with Saumil Pandya, SPH '99 (MHS)

saumil

Lifelong Learning Logo


Course Title: U.S. Healthcare/Pharma Reimbursement Market

Instructor: Saumil Pandya, SPH '99 (MHS)

Brought to you by Odyssey   

June 10, 2024 - July 15, 2024 (6 Sessions)  

Monday,  6 PM ET  

Virtual via Zoom 

 

 

Course Description: The U.S. healthcare reimbursement system consists of a mix of public and private third-party coverage, in which employers, individuals and the government all contribute to the costs related to healthcare. The financial dynamics of our healthcare system make it an extremely interesting topic of discussion regardless of whether you work in healthcare or not. Although healthcare has traditionally been the domain of payers and providers, every practicing healthcare administrator and supporting industries should understand the basic principles of the administration and financing of healthcare delivery. The pharmaceutical industry is no exception. Over the past few years, increased media and policymaker focus on the price of medicines has led to anger and frustration targeted at pharmaceutical manufacturers, pharmacy benefit managers (PBMs), and health plans. Drug pricing is a complex and often confusing issue, shaped by a pharmaceutical distribution and payment methodologies that involves multiple transactions among numerous stakeholders. 

The U.S. healthcare reimbursement system is diverse and complex, but in this course, we will focus on developing an understanding of the evolving U.S. healthcare landscape and the role of the pharmaceutical industry. Participants will gain a better understanding of the structure of the public and private players that comprise the U.S. healthcare reimbursement system with an emphasis on the pharmaceutical market. They will learn about the funding mechanisms behind our current reimbursement system, many of the misaligned financial incentives that exist. We will explore public/private sector roles, the impact of managed care and insurance, and the positive points and unintended consequences of the drug provisions in the Inflation Reduction Act, along with drug pricing/PBM reform policy proposals that are being considered to make our system function more efficiently.

______________________________________________________________________________________________________________________________

Johns Hopkins Tuition Remission Policies  

Johns Hopkins alumni, staff, faculty and their spouse or domestic partners are eligible for tuition remission for Odyssey lifelong learning courses. Select the correct ticket pricing during registration. If we cannot confirm your eligibility, you will be requested to pay the full registration price for the course.  Eligibility details can be found here. 

Withdrawals & Refunds: 

If a course is canceled or closed, the registrant is notified immediately, and a full refund is processed automatically unless another course is requested. Registrants who wish to withdraw from an active course must complete the online Odyssey Refund Request Form. Attach any documentation to support your request (e.g., medical documentation, family crisis documentation, etc.). 

100% refund- Prior to the start of the course. 

50% refund- During the first week of the course. 

No refunds will be given after the first week of each course unless in exceptional cases. 

Please note, refunds apply only to the tuition portion of an Odyssey participant’s charges and are not applicable to any fees or gifts made to the Johns Hopkins Alumni Association. Registrants will be notified by email if a refund is approved within (5) business days. 

ABOUT Saumil Pandya

Saumil Pandya is currently the Vice President of Market Access Strategy at NaviSync supporting the market access, pricing, policy, and brand teams for six branded products across two major pharmaceutical manufacturers. Most recently, Saumil was a Principal in the US Market Access Strategy Consulting team at IQVIA and was also advocating for the passage of the combination of the “Modernizing and Ensuring PBM Accountability Act” and the “Pharmacy Benefit Manager Reform Act” being considered by the US Senate Finance & HELP Committees. Both bills are based on the “delinking” drug pricing policy proposal that he developed several years ago. 

Saumil has over 20 years of experience in market access, managed care, medical economics, health policy, financial analysis and modeling, and pricing and contracting strategies across the consulting, health insurance and biopharmaceutical industries. He has gained a depth and breadth of experience by working in industries that span the health care spectrum and in doing so has gained first hand knowledge of how the financial interests of those industries intertwine and the pros and cons of how our health care system actually operates in practice.

FOLLOWLinkedin
 Follow us on

 Event Date
Starts:
Monday, June 10, 2024
6:00pm EDT

Ends:
Monday, July 15, 2024
7:30pm EDT

 Contact
Odyssey
1-800-JHU-JHU1 (548-5481)
odyssey@jhu.edu

$
80% discount. Employment status will be confirmed
$
80% discount. Employment status will be confirmed
$
50% discount. Employment status of Spouse/Partner will be confirmed
$
Student status will be confirmed

Registration Information

Make a Gift

$

Payment Information